Poly(glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo

Affiliations

• ¹ Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. [email protected].
• ² David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. [email protected] and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
• ³ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
• ⁴ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. [email protected] and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
• ⁵ Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute, Haifa 32000, Israel.
• ⁶ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. [email protected] and Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
• ⁷ Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. [email protected] and Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA and The Center for Clinical and Translational Science, The Ohio State University, Columbus, OH 43210, USA and The Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.